Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.4147
Delayed Data
As of Mar 23
 +0.0067 / +1.64%
Today’s Change
0.38
Today|||52-Week Range
4.40
-36.11%
Year-to-Date
Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
Mar 23 / Zacks.com - Paid Partner Content
Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase
Mar 17 / Zacks.com - Paid Partner Content
OvaScience, Inc. (OVAS) Looks Good: Stock Up 9.6% Higher
Mar 23 / Zacks.com - Paid Partner Content
Implied Volatility Surging for Anthera (ANTH) Stock Options
Mar 17 / Zacks.com - Paid Partner Content
Enzo Biochem, Inc. (ENZ) Shows Strength: Stock Up 5.2%
Mar 21 / Zacks.com - Paid Partner Content
Shire's (SHPG) Cinryze Label Expanded for Pediatric Use
Mar 16 / Zacks.com - Paid Partner Content
Fortress Biotech (FBIO) Catches Eye: Stock Moves Up 8.3%
Mar 20 / Zacks.com - Paid Partner Content
Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA
Mar 16 / Zacks.com - Paid Partner Content
AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher
Mar 20 / Zacks.com - Paid Partner Content
Inovio (INO) Q4 Loss Wider than Expected; Shares Decline
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.41
Today’s open0.40
Day’s range0.39 - 0.42
Volume2,195,058
Average volume (3 months)2,341,701
Market cap$32.8M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book5.39

Competitors

 Today’s
change
Today’s
% change
AXNAoxing Pharmaceutica...+0.01+1.22%
MRNSMarinus Pharmaceutic...-0.02-1.31%
CAPNCapnia Inc-0.02-2.55%
XBIOXenetic Biosciences ...-0.09-2.28%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs